Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Makuch

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Statistics in Medicine|April 1, 1985
Approaches to sample size estimation in the design of clinical trials--a reviewR Makuch
Journal of Clinical Epidemiology|January 1, 1989
Issues in planning and interpreting active control equivalence studiesR Makuch, M Johnson
Acta Biochimica Polonica|January 1, 1993
Motility assay: achievements and perspectivesR Makuch, D Stepkowski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts ProgramC Jacobs, R Makuch
Postepy Biochemii|January 1, 1992
[Caldesmon--regulator of the smooth muscle contraction and the phenomena of the movement of non-muscle cells]R Makuch, R Dabrowska
Cancer|July 1, 1979
Recommendations for the analysis of the effect of treatment on the development of second malignanciesR Makuch, R Simon
Cancer Treatment Reports|July 1, 1978
Sample size requirements for evaluating a conservative therapyR Makuch, R Simon
Lancet (London, England)|March 15, 2001
Blood-pressure-lowering treatmentG A Faich, R Makuch
FEBS Letters|February 10, 1992
The importance of C-terminal amino acid residues of actin to the inhibition of actomyosin ATPase activity by caldesmon and troponin IR Makuch, J Kołakowski, R Dabrowska
FEBS Letters|August 31, 1992
Lys-373 of actin is involved in binding to caldesmonJ Kołakowski, R Makuch, R Dabrowska
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Statistics in Medicine|April 1, 1985
Approaches to sample size estimation in the design of clinical trials--a reviewR Makuch
Journal of Clinical Epidemiology|January 1, 1989
Issues in planning and interpreting active control equivalence studiesR Makuch, M Johnson
Acta Biochimica Polonica|January 1, 1993
Motility assay: achievements and perspectivesR Makuch, D Stepkowski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts ProgramC Jacobs, R Makuch
Postepy Biochemii|January 1, 1992
[Caldesmon--regulator of the smooth muscle contraction and the phenomena of the movement of non-muscle cells]R Makuch, R Dabrowska
Cancer|July 1, 1979
Recommendations for the analysis of the effect of treatment on the development of second malignanciesR Makuch, R Simon
Cancer Treatment Reports|July 1, 1978
Sample size requirements for evaluating a conservative therapyR Makuch, R Simon
Lancet (London, England)|March 15, 2001
Blood-pressure-lowering treatmentG A Faich, R Makuch
FEBS Letters|February 10, 1992
The importance of C-terminal amino acid residues of actin to the inhibition of actomyosin ATPase activity by caldesmon and troponin IR Makuch, J Kołakowski, R Dabrowska
FEBS Letters|August 31, 1992
Lys-373 of actin is involved in binding to caldesmonJ Kołakowski, R Makuch, R Dabrowska
Pageof 7